Article: Non-HDL cholesterol level predicts vascular inflammation in type 2 diabetes.

2004 NOV 28 - (NewsRx.com & NewsRx.net) -- Non-HDL cholesterol level is a reliable early predictor for vascular inflammation in type 2 diabetes.

According to a study from Taiwan, "Although LDL is the primary target for lipid-lowering therapy and non-HDL cholesterol is a secondary target in patients with elevated triglyceride (TG) levels, non-HDL cholesterol is still an early, reliable, and practical a predictor for vascular inflammation. However, in comparison with LDL, further evidence for superiority in non-HDL cholesterol as the primary therapeutic target is required. A total of 189 type 2 diabetic patients (88 men and 101 women; mean age 58.4[+ or -]14.0 ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!